. Author manuscript; available in PMC: 2017 Apr 1.

Published in final edited form as: Schizophr Res. 2016 Feb 28;172(1-3):101–105. doi: 10.1016/j.schres.2016.02.017

Table 2. Metabolite concentrations for controls and schizophrenia patients.

ACC metabolite concentrations for 24 controls and 24 patients with schizophrenia. Data are presented as mean (standard deviation). A cutoff of p < 0.05 was used for significance.

	Control	Patient	t Test (p)
Glu	9.05 (0.72)	9.16 (1.66)	n.s.
Gln	2.42 (0.51)	2.32 (0.64)	n.s.
Gln/Glu	0.27 (0.06)	0.25 (0.01)	n.s.
NAA	7.87 (0.76)	7.33 (1.83)	n.s.
NAAG	0.68 (0.24)	0.87 (0.52)	n.s.
mI	6.69 (0.88)	6.36 (1.34)	n.s.
GABA	2.24 (0.31)	2.36 (0.41)	n.s.
GSH	1.73 (0.22)	1.74 (0.31)	n.s.
tCr	6.44 (0.58)	6.21 (1.15)	n.s.
tCh	2.16 (0.29)	2.10 (0.47)	n.s.